News for Conifer Holdings, Inc. (CNFR)

Conifer Holdings Inc. flipped to a third-quarter $52.8 million allocable net income from a $2.7 million net loss a year earlier, helped by a $61 million gain on the August sale of its insurance

**media[465440]**

Bishop Street Underwriters, a multi-boutique insurance platform owned by RedBird Capital Partners, announced it has acquired Conifer Insurance Services a

Multi-boutique insurance platform Bishop Street Underwriters said it has acquired Conifer Insurance Services, a managing general agent unit of Conifer Holdings Inc.

Oregon-based Eastside Distilling, Inc. (EAST) is up over 278 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Conifer Holdings stock hits 52-week high at $1.71

Conifer Holdings Inc. said its co-founder and chief executive officer has resigned to work for the unnamed company that acquired Conifer’s insurance agency operations for at $45 million to $70

Shares of GitLab Inc. GTLB rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter financial results and issue...

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 2% on Tuesday. The Dow traded down 1.49% to 40,944.47 while the NASDAQ fell...

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 1% on Tuesday. The Dow traded down 0.94% to 41,173.76 while the NASDAQ f...

Shares of Rumble Inc. RUM rose sharply in today's pre-market trading following better-than-expected second-quarter financial results. Rumble reported second-qu...

Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday.

With U.S. stock futures trading lower Monday morning, some of the stocks that may grab investor focus today are as follows:

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.